{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:11:07Z","timestamp":1769166667431,"version":"3.49.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jcte.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T22:12:29Z","timestamp":1537999949000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Less known aspects of central hypothyroidism: Part 1 \u2013 Acquired etiologies"],"prefix":"10.1016","volume":"14","author":[{"given":"Salvatore","family":"Benvenga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Klose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-3062","authenticated-orcid":false,"given":"Roberto","family":"Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-3355","authenticated-orcid":false,"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2018.09.003_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11102-008-0122-6","article-title":"Central hypothyroidism","volume":"11","author":"Lania","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.jcte.2018.09.003_b0010","series-title":"Werners & Ingbar\u2019s The thyroid. A clinical and fundamental text","first-page":"560","article-title":"Central hypothyroidism","author":"Persani","year":"2013"},{"key":"10.1016\/j.jcte.2018.09.003_b0015","first-page":"1124","article-title":"Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3, 5, 3-triiodothyronine response to TSH and in vitro bioactivity of TSH","volume":"80","author":"Horimoto","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/105072503321086962","article-title":"Laboratory support for the diagnosis and monitoring of thyroid disease","volume":"13","author":"Baloch","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2018.09.003_b0025","first-page":"83","article-title":"Investigating the pathways in primary practice leading to the diagnosis of central hypothyroidism","volume":"125","author":"Gibbons","year":"2012","journal-title":"N Z Med J"},{"key":"10.1016\/j.jcte.2018.09.003_b0030","series-title":"Greenspan\u2019s basic & clinical endocrinology","first-page":"209","article-title":"The thyroid gland","author":"Cooper","year":"2007"},{"key":"10.1016\/j.jcte.2018.09.003_b0035","series-title":"Williams textbook of endocrinology","first-page":"423","article-title":"Hypothyroidism and thyroiditis","author":"Larsen","year":"2003"},{"key":"10.1016\/j.jcte.2018.09.003_b0040","series-title":"Werners & Ingbar\u2019s The thyroid. A clinical and fundamental text","first-page":"797","article-title":"Hypothyroidism in infants, children and adolescents: acquired hypothyroidism","author":"Van Vliet","year":"2013"},{"key":"10.1016\/j.jcte.2018.09.003_b0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/B978-0-444-59602-4.00027-7","article-title":"Uncertainties in endocrine substitution therapy for central endocrine insufficiencies: hypothyroidism","volume":"124","author":"Persani","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jcte.2018.09.003_b0050","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Thyroid association task force on thyroid hormone replacement. guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2018.09.003_b0055","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)04248-3","article-title":"Pitfalls in the use of thyrotropin concentration as a first line thyroid-function test","volume":"357","author":"Wardle","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jcte.2018.09.003_b0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(98)85043-5","article-title":"Pituitary insufficiency","volume":"352","author":"Lamberts","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcte.2018.09.003_b0065","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/jc.2013-2409","article-title":"The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis","volume":"99","author":"Garmendia Madariaga","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult caucasian population in Northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0075","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1210\/jc.2005-0504","article-title":"Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study","volume":"90","author":"Aimaretti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrneurol.2013.22","article-title":"Changing patterns in the epidemiology of traumatic brain injury","volume":"9","author":"Roozenbeek","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jcte.2018.09.003_b0085","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.298.12.1429","article-title":"Agha A Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review","volume":"298","author":"Schneider","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcte.2018.09.003_b0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrendo.2017.103","article-title":"Chronic endocrine consequences of traumatic brain injury - what is the evidence?","volume":"14","author":"Klose","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0095","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/eje.1.02284","article-title":"Hypopituitarism in childhood and adolescence following traumatic brain injury: the case for prospective endocrine investigation","volume":"155","author":"Acerini","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12020-015-0796-2","article-title":"Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS)","volume":"52","author":"Karamouzis","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.jcte.2018.09.003_b0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.14310\/horm.2002.1111013","article-title":"Endocrine evaluation of patients after brain injury: what else is needed to define specific clinical recommendations?","volume":"6","author":"Sesmilo","year":"2007","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.jcte.2018.09.003_b0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/jc.2013-2397","article-title":"Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism","volume":"99","author":"Klose","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0115","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2146\/ajhp150964","article-title":"Examination of medication clinical decision support using Bayes' theorem","volume":"73","author":"Payne","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jcte.2018.09.003_b0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.amjmed.2003.12.038","article-title":"Severe head trauma in patients with unexplained central hypothyroidism","volume":"116","author":"Benvenga","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jcte.2018.09.003_b0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/124.2.249","article-title":"Subarachnoid haemorrhage: diagnosis, causes and management","volume":"124","author":"van Gijn","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jcte.2018.09.003_b0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3171\/jns.2000.93.5.0743","article-title":"Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report","volume":"93","author":"Kelly","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jcte.2018.09.003_b0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.beem.2011.06.001","article-title":"Pituitary dysfunction following traumatic brain injury or subarachnoid haemorrhage - in \u201cEndocrine Management in the Intensive Care Unit\u201d","volume":"25","author":"Hannon","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1179\/016164107X165633","article-title":"Pituitary dysfunction after aneurysmal subarachnoid hemorrhage","volume":"29","author":"Kagerbauer","year":"2007","journal-title":"Neurol Res"},{"key":"10.1016\/j.jcte.2018.09.003_b0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11102-006-6044-2","article-title":"Subarachnoid hemorrhage as a cause of hypopituitarism","volume":"8","author":"Kreitschmann-Andermahr","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.jcte.2018.09.003_b0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12883-014-0205-0","article-title":"Hypopituitarism after subarachnoid haemorrhage, do we know enough?","volume":"14","author":"Khajeh","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jcte.2018.09.003_b0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.0001-6314.2003.00189.x","article-title":"Fatigue after aneurysmal subarachnoid hemorrhage evaluated by pituitary function and 3D-CBF","volume":"109","author":"Brandt","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jcte.2018.09.003_b0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1227\/NEU.0000000000001157","article-title":"Pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"79","author":"Can","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jcte.2018.09.003_b0165","first-page":"457","article-title":"Traumatic brain injury and subarachnoid hemorrhage as a cause of hypopituitarism: a review","volume":"64","author":"Valdes-Socin","year":"2009","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.jcte.2018.09.003_b0170","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1210\/jc.2015-2152","article-title":"Pituitary working group of the german society of endocrinology diagnosis of primary hypophysitis in Germany","volume":"100","author":"Honegger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2004-0011","article-title":"Autoimmune hypophysitis","volume":"26","author":"Caturegli","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jcte.2018.09.003_b0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ecl.2014.10.011","article-title":"Hypophysitis","volume":"44","author":"Fukuoka","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jcte.2018.09.003_b0185","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2018.09.003_b0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000446544","article-title":"An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Prospective Single-Center Experience","volume":"104","author":"Chiloiro","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jcte.2018.09.003_b0195","unstructured":"Chung T, Monson J. Hypopituitarism. Available from: www.endotext.org."},{"key":"10.1016\/j.jcte.2018.09.003_b0200","first-page":"1789","article-title":"The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas","volume":"85","author":"Arafah","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0205","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Endocrine Society. Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1590\/S0004-27302009000100006","article-title":"Non-functioning pituitary adenomas: clinical feature, laboratorial and imaging assessment, therapeutic management and outcome","volume":"53","author":"Cury","year":"2009","journal-title":"Arq Bras Endocrinol Metabol."},{"key":"10.1016\/j.jcte.2018.09.003_b0215","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/eje.1.02298","article-title":"Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors","volume":"155","author":"Ferrante","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0220","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1742-1241.2010.02537.x","article-title":"Pituitary incidentalomas: a single-centre experience","volume":"65","author":"Anagnostis","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jcte.2018.09.003_b0225","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2265.2012.04442.x","article-title":"ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types","volume":"77","author":"Mathioudakis","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2018.09.003_b0230","series-title":"Williams textbook of Endocrinology","first-page":"177","article-title":"Anterior Pituitary","author":"Melmed","year":"2003"},{"key":"10.1016\/j.jcte.2018.09.003_b0235","series-title":"Handbook of clinical neurology","first-page":"317","article-title":"Surgical approach to pituitary tumors","author":"Solari","year":"2014"},{"key":"10.1016\/j.jcte.2018.09.003_b0240","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","article-title":"The long term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas","volume":"38","author":"Brada","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2018.09.003_b0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2012.03.021","article-title":"Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas","volume":"104","author":"Sicignano","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jcte.2018.09.003_b0250","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/pbc.25064","article-title":"Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols","volume":"61","author":"Saha","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcte.2018.09.003_b0255","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/cncr.11095","article-title":"Childhood cancer survivor study. endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: childhood cancer survivor study","volume":"97","author":"Gurney","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jcte.2018.09.003_b0260","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1515\/JPEM.2011.407","article-title":"Central hypothyroidism following chemotherapy for acute lymphoblastic leukemia","volume":"24","author":"Baronio","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0265","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/pbc.25176","article-title":"High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs","volume":"61","author":"Clement","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcte.2018.09.003_b0270","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2008.13.5293","article-title":"Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial","volume":"26","author":"Laughton","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcte.2018.09.003_b0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.medici.2014.10.006","article-title":"Early development of endocrine and metabolic consequences after treatment of central nervous system tumors in children","volume":"50","author":"Ramanauskien\u0117","year":"2014","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jcte.2018.09.003_b0280","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ijc.26086","article-title":"Hypothyroidism following childhood cancer therapy-an under diagnosed complication","volume":"130","author":"Brabant","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcte.2018.09.003_b0285","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/jc.2002-020380","article-title":"A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.2001.01292.x","article-title":"Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation","volume":"55","author":"Lando","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2018.09.003_b0295","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1210\/jc.2005-1593","article-title":"Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors","volume":"90","author":"Darzy","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0300","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1210\/jc.2003-030209","article-title":"No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer","volume":"88","author":"van Santen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0305","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrendo.2016.45","article-title":"Late endocrine effects of childhood cancer","volume":"12","author":"Rose","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0310","unstructured":"Epidemiology of Meningitis and Ventriculitis in Children. The ISPN Guide to Pediatric Neurosurgery https:\/\/www.ispn.guide\/infections-of-the-nervous-system-in-children\/meningitis-and-ventriculitis-in-children-homepage\/epidemiology-of-meningitis-and-ventriculitis-in-children\/ [Accessed 5 June 2018]."},{"key":"10.1016\/j.jcte.2018.09.003_b0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1530\/EJE-07-0484","article-title":"Hypothalamic-pituitary insufficiency following infectious diseases of the central nervous system","volume":"158","author":"Schaefer","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0320","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11102-013-0476-2","article-title":"Pituitary function in children following infectious diseases of the central nervous system","volume":"17","author":"Levy-Shraga","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.jcte.2018.09.003_b0325","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11102-011-0371-7","article-title":"Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity?","volume":"15","author":"Tanriverdi","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.jcte.2018.09.003_b0330","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1472-6823-14-80","article-title":"Evaluation of pituitary function after infectious meningitis in childhood","volume":"14","author":"Giavoli","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jcte.2018.09.003_b0335","doi-asserted-by":"crossref","first-page":"308","DOI":"10.11604\/pamj.2015.20.308.6538","article-title":"Hypopituitarism as consequence of late neonatal infection by Group B streptococcus: a case report","volume":"20","author":"Ferreira","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jcte.2018.09.003_b0340","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-3476(76)81002-5","article-title":"Hypothalamic-pituitary dysfunction following group B beta hemolytic streptococcal meningitis in a neonate","volume":"88","author":"Pai","year":"1976","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcte.2018.09.003_b0345","doi-asserted-by":"crossref","first-page":"272","DOI":"10.12968\/hmed.2007.68.5.23336","article-title":"Bacterial meningitis resulting in visual impairment and panhypopituitarism","volume":"68","author":"Lynch","year":"2007","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.jcte.2018.09.003_b0350","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2169\/naika.78.684","article-title":"A case of empty sella syndrome with panhypopituitarism following acute meningoencephalitis","volume":"78","author":"Muraoka","year":"1989","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"10.1016\/j.jcte.2018.09.003_b0355","unstructured":"Salaspuro M. Impotence, obscure fever, meningitis and panhypopituitarism. A clinical-pathological conference. Duodecim 1975;91:1557\u201366."},{"key":"10.1016\/j.jcte.2018.09.003_b0360","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1590\/0004-2730000002701","article-title":"Spontaneous remission of acromegaly: apoplexy mimicking meningitis or meningitis as a cause of apoplexy?","volume":"58","author":"Villar-Taibo","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.jcte.2018.09.003_b0365","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1471-2334-13-481","article-title":"Acute hypophysitis and hypopituitarism in early syphilitic meningitis in a HIV-infected patient: a case report","volume":"13","author":"Spinner","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jcte.2018.09.003_b0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/qjmed\/hct193","article-title":"The causes of hypopituitarism in the absence of abnormal pituitary imaging","volume":"107","author":"Wilson","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.jcte.2018.09.003_b0375","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF03401312","article-title":"A case of Dyke-Davidoff-Masson syndrome associated with central hypothyroidism and secondary adrenal insufficiency","volume":"12","author":"Kim","year":"2013","journal-title":"Hormones"},{"key":"10.1016\/j.jcte.2018.09.003_b0380","first-page":"316","article-title":"A case of dyke-davidoff-masson syndrome associated with hypopituitarism and diabetes mellitus","volume":"79","author":"Park","year":"2010","journal-title":"Korean J Med"},{"key":"10.1016\/j.jcte.2018.09.003_b0385","doi-asserted-by":"crossref","first-page":"385","DOI":"10.17712\/nsj.2015.4.20150481","article-title":"Dyke-Davidoff-Masson syndrome. An unusual cause of status epilepticus","volume":"20","author":"Zawar","year":"2015","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.jcte.2018.09.003_b0390","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2009.05.009","article-title":"Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary","volume":"23","author":"Carpinteri","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0395","doi-asserted-by":"crossref","first-page":"R269","DOI":"10.1530\/EJE-16-1065","article-title":"Diagnosis of endocrine disease: expanding the cause of hypopituitarism","volume":"176","author":"Pekic","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0400","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","article-title":"Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients","volume":"105","author":"Langrand","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.jcte.2018.09.003_b0405","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpeds.2003.12.030","article-title":"Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study","volume":"144","author":"Donadieu","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcte.2018.09.003_b0410","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s11102-017-0811-0","article-title":"Pituitary dysfunction in granulomatosis with polyangiitis","volume":"20","author":"Esposito","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.jcte.2018.09.003_b0415","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ccr3.1007","article-title":"Granulomatous hypophysitis: rare disease with challenging diagnosis","volume":"5","author":"Elgamal","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jcte.2018.09.003_b0420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2169\/internalmedicine1962.30.164","article-title":"Hypopituitarism associated with Cogan's syndrome; high-dose glucocorticoid therapy reverses pituitary swelling","volume":"30","author":"Kanatani","year":"1991","journal-title":"Jpn J Med"},{"key":"10.1016\/j.jcte.2018.09.003_b0425","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1507\/endocrj.EJ13-0419","article-title":"Erdheim-Chester disease and pituitary involvement: a unique case and the literature","volume":"61","author":"Manaka","year":"2014","journal-title":"Endocr J"},{"key":"10.1016\/j.jcte.2018.09.003_b0430","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.beem.2009.08.003","article-title":"Drugs that suppress TSH or cause central hypothyroidism","volume":"23","author":"Haugen","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0435","first-page":"1388","article-title":"Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study","volume":"85","author":"Samuels","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0440","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2265.1994.tb02787.x","article-title":"Dopamine and the sick euthyroid syndrome in critical illness","volume":"41","author":"Van den Berghe","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0445","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/eje.0.1330189","article-title":"Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas","volume":"133","author":"Colao","year":"1995","journal-title":"Eur J Endcrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0450","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.beem.2009.05.006","article-title":"Pituitary tumours: TSH-secreting adenomas","volume":"23","author":"Beck-Peccoz","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0455","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1210\/jc.2010-0409","article-title":"Approach to the patient with resistance to thyroid hormone and pregnancy","volume":"95","author":"Weiss","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0460","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jcem.87.7.8665","article-title":"Somatostatin analogs in acromegaly","volume":"77","author":"Freda","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0465","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1677\/ERC-08-0103","article-title":"Prospective evaluation of mitotane toxicity in adrenocortical cancer patient treated adjuvantly","volume":"15","author":"Daffara","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcte.2018.09.003_b0470","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/en.2009-1404","article-title":"Therapeutic concentrations of mitotane (o, p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model","volume":"151","author":"Zatelli","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.jcte.2018.09.003_b0475","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/cen.12868","article-title":"Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism","volume":"84","author":"Russo","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2018.09.003_b0480","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJM199904083401404","article-title":"Central hypothyroidism associated with retinoid X receptor-selective ligands","volume":"340","author":"Sherman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2018.09.003_b0485","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1210\/jc.2006-2822","article-title":"Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones","volume":"92","author":"Smit","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0490","first-page":"394","article-title":"Drug-induced hypothyroidism","volume":"77","author":"Rizzo","year":"2017","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.jcte.2018.09.003_b0495","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2340\/00015555-1302","article-title":"Oral alitretinoin in congenital ichthyosis: a pilot study shows variable effects and a risk of central hypothyroidism","volume":"92","author":"G\u00e5nemo","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jcte.2018.09.003_b0500","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/thy.1993.3.325","article-title":"Hershman JM Suppression of rat thyrotroph and thyroid cell function by tumor necrosis factor-alpha","volume":"3","author":"Pang","year":"1993","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2018.09.003_b0505","first-page":"3140","article-title":"(1995) Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men","volume":"80","author":"Corssmit","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0510","doi-asserted-by":"crossref","first-page":"67129","DOI":"10.18632\/oncotarget.18004","article-title":"Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcte.2018.09.003_b0515","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1210\/jc.2012-4075","article-title":"Endocrine side effects induced by immune checkpoint inhibitors","volume":"98","author":"Corsello","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0520","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PPO.0000000000000186","article-title":"Managing adverse events with immune checkpoint agents","volume":"22","author":"Dadu","year":"2016","journal-title":"Cancer J"},{"key":"10.1016\/j.jcte.2018.09.003_b0525","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11102-015-0671-4","article-title":"Immunotherapy and hypophysitis: clinical presentantion, treatment, and biologic insights","volume":"19","author":"Faje","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.jcte.2018.09.003_b0530","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-14-0845","article-title":"Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma","volume":"172","author":"Albarel","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0535","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1634\/theoncologist.2015-0509","article-title":"Immune checkpoint inhibitors: review and management of endocrine adverse effects","volume":"21","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.jcte.2018.09.003_b0540","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.seminoncol.2017.06.007","article-title":"Nivolumab and pembrolizumab: monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable","volume":"44","author":"Prasad","year":"2017","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcte.2018.09.003_b0545","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2017.08.019","article-title":"Cancer immunotherapy-induced endocrinopathies: clinical behavior and therapeutic approach","volume":"47","author":"Iglesias","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jcte.2018.09.003_b0550","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrendo.2016.205","article-title":"Cancer immunotherapy \u2013 immune checkpoint blockade and associated endocrinopathies","volume":"13","author":"Byun","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b0555","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12020-016-1047-x","article-title":"Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients","volume":"54","author":"Feldt-Rasmussen","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.jcte.2018.09.003_b0560","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1210\/jc.2013-1610","article-title":"Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients","volume":"98","author":"Klose","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.09.003_b0565","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1530\/EJE-16-0193","article-title":"Diagnosis of endocrine disease: how reliable are free thyroid and total T3 hormone assays?","volume":"175","author":"Welsh","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2018.09.003_b9000","first-page":"5","article-title":"Less known aspects of central hypothyroidism: Part 2 - Congenital etiologies","volume":"14","author":"Benvenga","year":"2018","journal-title":"J Clin Transl Endocrinol"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221462371830067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221462371830067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:55:07Z","timestamp":1762005307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221462371830067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":114,"alternative-id":["S221462371830067X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2018.09.003","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Less known aspects of central hypothyroidism: Part 1 \u2013 Acquired etiologies","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}